Maru Arias completed a B.Sc in Biochemistry in 2012 from Concordia University. As a Co-op student and after completion of her undergraduate degree she acquired research and industrial experience in the pharmaceutical (PerkinElmer, MediMAbs and Boehringer Ingelheim) and cosmetic (L’Oréal) industries. She returned to academics to consolidate and further her research and industrial experience at McGill University. She completed an M.Eng in Biological and Biomedical Engineering in three terms with a heavy course load obtaining a 4.0 GPA. Her master’s research was focused on protein adsorption prediction models based on statistical and numerical analysis of values measured in literature.
Maru's Ph.D project involves the development and optimization of processes for cell encapsulation aimed at therapeutic applications.
Omar Bashth graduated in 2016 with a bachelor's degree in chemical engineering with focus on petrochemicals.
M.Eng. (thesis) candidate
Omar's project focuses on surface modification with biomolecule conjugation strategies to capture and promote the adhesion of endothelial progenitor cells (EPCs) to vascular biomaterials. His long-term goal is to design a bioresorbable stent that would promote reendothelialization on the surface to overcome in-stent restenosis and thrombosis.
Ariane completed her Bachelor of Chemical Engineering at McGill University in 2016. She worked as an undergraduate trainee under the supervision of Prof. Corinne Hoesli on a project titled Interactions between immune cells and alginate beads.
M.Eng. (thesis) candidate
Ariane studies the effects of flow on endothelial cells derived from induced pluripotent stem cells (iPSC) obtained from Hutchison-Gilford Progeria Syndrome (HGPS) patients.
Olivia was born and raised in Montreal, Quebec. During her undergraduate studies, Olivia worked under the supervision of Prof. Corinne Hoesli and Ph.D. candidate Mohamed Elkhodiry. Her project involved evaluating the adhesion capabilities of various extracellular matrix-derived peptides to endothelial colony-forming cells.
Olivia studies cell-surface interactions in the context of dendritic cell production for cancer immunotherapy.
Mohamed Elkhodiry completed a Bachelor of Science in Chemical Engineering in 2015 at the American University of Sharjah, Sharjah, UAE. During his undergraduate degree, Mohamed worked in Prof. Alhusseini’s Lab where his research focused on creating surface modified nano-carriers for chemotherapeutic drug delivery.
Mohamed studies the utilisation of endothelial progenitor cells (EPCs) in promoting endothelialisation of vascular stents via surface modification. The aim of the project is to create a new generation of vascular stents that not only prevent stenosis, but also promote vascular healing.
Jonathan completed his undergraduate studies in Chemical Engineering at Laval University, Quebec City. He worked as a summer student on various projects including blood vessel fabrication (Prof. Diego Mantovani), induced pluripotent stem cell (iPSC) differentiation (Prof. Alain Garnier) and vascular aging (Prof. Corinne Hoesli). He then completed a Master in Bioengineering under the supervision of Prof. Matthias Lütolf at École Polytechnique Fédérale de Lausanne (EPFL).
Jonathan is working on the conception of a bioartificial pancreas for the treatment of type 1 diabetes.
Lisa Danielczak completed her Bachelor of Science at the University of Waterloo. She has worked as a technician in labs in Ontario, England and Quebec City before coming to McGill, where she has worked since 2008.
Lisa works on a variety of projects, including the engineering of a vascularized bioartificial pancreas.
Stephanie Fernandez completed a Bachelor of Science with a major in Biochemistry in 2010 at McGill University, Montreal, Canada. She then completed a second Bachelor degree at McGill University in Chemical Engineering, graduating in 2014. Her undergraduate research, performed in the laboratory of Prof. R. Leask, involved the use of atomic force microscopy to measure endothelial cell stiffness as a potential marker for disease.
Stephanie entered the Master’s program in 2014 and transferred to the Doctoral program in September 2015. Her current research project involves the development of a perfusable transplantation device for the treatment of type 1 diabetes. This work incorporates pancreatic islet encapsulation and 3D printing methods, aiming to improve the success and longevity of islet transplantation treatment.
Julia completed a Bachelor of Science, Honours Biochemistry degree in 2014 at the University of Waterloo. During her undergraduate degree, she held co-op positions at the Hospital for Sick Children in Toronto and was involved in the Waterloo iGEM team. In 2018, she completed a Master of Applied Science in Chemical Engineering at the University of Waterloo. Her thesis was titled Investigation of excipients for the stabilization of HSV-2 vaccine candidate ACAM529.
Julia's research focuses on studying endothelial progenitor cell differentiation, through the development of novel genetic tools, for applications in vascular disease treatments.
Brenden completed his undergraduate degree in Winter 2017, majoring in Chemical Engineering and minoring in Biotechnology. In Summer 2015, he worked as an undergraduate researcher under the supervision of Prof. Milan Maric, synthesizing and developing a reactively-blended polymer to be used as a barrier material for an industrial oil storage application. In 2016, Brenden worked in the Stem Cell Bioprocessing Lab under the supervision of Prof. C. Hoesli and Stephanie Fernandez. His project involved the characterization and optimization of a carbohydrate glass ink used in 3D printing dissolvable structures as a means of achieving artificial vascularization in cellular transplants.
Brenden's project involves developing methods for bioprinting cell-laden hydrogels, such as alginate, for applications in diabetes cell therapy.
Will is a fourth-year Bioengineering student at McGill University. In his free time, he likes to go around Montreal and try out different dumpling restaurants.
Undergraduate intern - mentored by Omar Bashth
Will is currently studying cell-surface interaction of Mesenchymal Stem Cells (MSCs).
Balaji is from Madurai City in Tamil Nadu, India. In 2009, he completed his B.Tech in Biotechnology at Mepco Schlenk Engineering College, affiliated with Anna University. In 2011, he completed his M.Tech in Biotechnology at West Bengal University of Technology. He completed his Ph.D. at the Indian Institute of Technology Madras in 2019. During his Ph.D., he worked on the project entitled “Surface modification of poly (ethylene terephthalate) to enhance haemocompatibility and endothelialization” under the guidance of Dr. Vignesh Muthuvijayan.
Currently, Balaji is part of an industrial project which explores the surface modification of polymers for promoting the biological response in cell-based cancer immunotherapy.
Dongjin completed his Bachelor of Chemical & Biological Engineering at Korea University, in Seoul, South Korea, where he worked as an undergraduate intern under the supervision of faculty members. His project involved synthesis of Gold nanoparticles for biosensor applications and hydrogel synthesis using microchannel cross-linking process.
M. Eng. (project) candidate
Dongjin’s project focuses on enhancing cell encapsulation efficiency using microchannel emulsification.
Ray is originally from Toronto, Ontario and he obtained his undergraduate degree in Chemical Engineering at the University of Waterloo. Outside of the lab, Ray enjoys cooking, watching movies, and exercising.
Ray's research involves understanding and optimizing the differentiation of induced pluripotent stem cells (iPSCs) into functional insulin-secreting beta cells with regards to different substrate properties, soluble signals and culture dimensionality.
Nabil Zeidan completed his Bachelor of Science in Biology in 2009 at Concordia University. In 2012, he completed his Master of Science in Immunology under the supervision of Dr. Alexander Abdelnoor, at the American University of Beirut, Beirut, Lebanon. His thesis was entitled The effect of atorvastatin on skin allograft survival and tumor growth cells in mice. In 2019, he completed his Ph.D. at the Université de Montréal under the joint supervision of Dr. Denis Claude Roy and Vibhuti Dave. His thesis was entitled The role of ThPOK and T cell receptor signaling in CD4 versus CD8 T cell lineage fate.
Nabil works on a multidisciplinary industrial project that is focused on better elucidating the effects of surface properties on dendritic cell-based cancer immunotherapies under GMP protocols.